Linda Wu ESA-SRB-ANZBMS 2021

Abstracts this author is presenting:

• Checkpoint inhibitor associated autoimmune diabetes: an emerging and fulminant form of type 1 diabetes — ESA Blended Orals - Immunotherapy and Vitamin D